Verapamil Hydrochloride
- Product NDC
- 51754-0204
- 11-digit product format
- 517540204
- Labeler code
- 51754
- Product ID
- 51754-0204_f1a97533-a1b0-4b0e-b4c2-76d5bee9b4e2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- EXELA PHARMA SCIENCES, LLC
- Application
- NDA018925
- Marketing category
- NDA
- Marketing start
- 2017-02-01
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Verapamil Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V3888OEY5R |
| Rxcui | 1665057 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51754-0204 | VERAPAMIL HYDROCHLORIDE INJECTION [EXELA PHARMA SCIENCES, LLC] | 1 | Current NDC, Legacy NDC | 20170201_3318e357-0660-44f4-8170-91a51bd762fb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51754-0204-2 | 51754020402 | 5 VIAL in 1 CARTON (51754-0204-2) / 2 mL in 1 VIAL | 5 vial | 2017-02-01 | 0000-00-00 | No | No | Current |
| 51754-0204-4 | 51754020404 | 25 VIAL in 1 CARTON (51754-0204-4) / 2 mL in 1 VIAL | 25 vial | 2017-02-01 | 0000-00-00 | No | No | Current |